1-9 of 9
D. Grinblatt
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Factors Affecting the Results of Allogeneic Hematopoietic Stem Cell Transplantation in Hematologic Malignancies

J. Mehta, O. Frankfurt, J. Altman, Andrew M Evens, DO, MS, L. Gordon, M. Tallman, S. Williams, J. Winter, J. Krishnamurthy, D. Grinblatt, L. Kaminer, S. Singhal
Journal: Blood
Blood (2008) 112 (11): 4386.
https://doi.org/10.1182/blood.V112.11.4386.4386
Published: 2008
Journal Articles

Outcome of Submyeloablative Allogeneic HSCT for Hematologic Malignancies: Development of a Prognostic Model Based on Pre-Transplant Characteristics.

Jayesh Mehta, A. Evens, O. Frankfurt, L. Gordon, D. Grinblatt, L. Kaminer, R. Meagher, M. Tallman, S. Williams, J. Winter, S. Singhal
Journal: Blood
Blood (2005) 106 (11): 1145.
https://doi.org/10.1182/blood.V106.11.1145.1145
Published: 2005
Journal Articles

The Effect of the Platelet Content of Blood Stem Cell Grafts on GVHD.

Jayesh Mehta, R. Meagher, A. Evens, O. Frankfurt, S. Singhal, M. Tallman, S. Williams, J. Winter, D. Grinblatt, L. Kaminer, L. Gordon
Journal: Blood
Blood (2005) 106 (11): 1077.
https://doi.org/10.1182/blood.V106.11.1077.1077
Published: 2005
Journal Articles

Identifying Patients at Risk of Early Relapse after Submyeloablative Allogeneic HSCT.

Jayesh Mehta, L. Gordon, M. Tallman, J. Winter, S. Williams, A. Evens, O. Frankfurt, D. Grinblatt, L. Kaminer, R. Meagher, S. Singhal
Journal: Blood
Blood (2005) 106 (11): 5390.
https://doi.org/10.1182/blood.V106.11.5390.5390
Published: 2005
Journal Articles

Ideal (IBW) Rather Than Actual (ABW) Body Weight Should Be Used To Calculate Cell Dose in Allogeneic HSCT.

Seema Singhal, A. Evens, O. Frankfurt, L. Gordon, R. Meagher, M. Tallman, S. Williams, J. Winter, D. Grinblatt, L. Kaminer, J. Mehta
Journal: Blood
Blood (2005) 106 (11): 1765.
https://doi.org/10.1182/blood.V106.11.1765.1765
Published: 2005
Journal Articles

Graft CD3+ Cell Content Affects Acute GVHD after Submyeloablative Allogeneic HSCT.

Seema Singhal, A. Evens, O. Frankfurt, L. Gordon, R. Meagher, M. Tallman, S. Williams, J. Winter, L. Kaminer, D. Grinblatt, J. Mehta
Journal: Blood
Blood (2005) 106 (11): 3663.
https://doi.org/10.1182/blood.V106.11.3663.3663
Published: 2005
Journal Articles

Pre-Transplant Variables Affecting the Outcome of Submyeloablative Allogeneic HSCT in Uniformly Treated Patients with Hematologic Malignancies.

Jayesh Mehta, S. Singhal, M. Tallman, S. Williams, J. Winter, A. Evens, D. Grinblatt, L. Kaminer, L. Gordon
Journal: Blood
Blood (2004) 104 (11): 2324.
https://doi.org/10.1182/blood.V104.11.2324.2324
Published: 2004
Journal Articles

Is a Younger 10-Allele-Matched Unrelated Donor (MUD) Better Than an Older 6-Antigen-Matched Sibling Donor (MSD) for Allogeneic HSCT?.

Jayesh Mehta, L. Gordon, M. Tallman, J. Winter, S. Williams, A. Evens, D. Grinblatt, L. Kaminer, S. Singhal
Journal: Blood
Blood (2004) 104 (11): 2757.
https://doi.org/10.1182/blood.V104.11.2757.2757
Published: 2004
Journal Articles

The CD34+ Cell Dose, Even in an "Acceptable" Range, Affects Outcome of Allogeneic Blood Stem Cell Transplantation.

Seema Singhal, L. Gordon, R. Meagher, A. Evens, M. Tallman, S. Williams, J. Winter, D. Grinblatt, L. Kaminer, J. Mehta
Journal: Blood
Blood (2004) 104 (11): 1153.
https://doi.org/10.1182/blood.V104.11.1153.1153
Published: 2004